Solutions

Online Inquiry

* Your Name

* Phone Number

* E-mail Address

* Services Interested

Project Description

Please note that we are a research service provider, not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Photophobia

Photophobia, or intolerance to light, accompanies numerous ophthalmic and neurological conditions. Here at Protheragen, we have broad offerings of therapeutic development services for photophobia. Together with our clients, we design custom therapeutic approach plans that aim at the particular neural circuits which photophobia is associated with.

Overview of Photophobia

Photophobia, often considered as an abnormal intolerance to light, is a complex condition that affects quality of life and is multifaceted in nature. It is accompanied by heightened discomfort to light which often results in anguish or distress. Several neurologic and ophthalmologic disorders such as migraine, blepharospasm, traumatic brain injury, and dry eye syndrome are associated with photophobia. As common as it is, photophobia is still missed on the diagnosis and therapeutics front emphasizing the importance of advanced therapeutic and diagnostic methods.

Correlation of light sensitivity with visually triggered dizziness.

Fig.1 Correlation between light sensitivity and visual trigger-induced dizziness. (Zou X., et al., 2024)

Diagnostics Development for Photophobia

Imaging Studies
The diagnosis of photophobia has undergone changes due to modern imaging technologies like functional magnetic resonance imaging (fMRI) and positron emission tomography (PET). These tools enable the visualization of brain structures that respond to light, as well as the neural circuits related to photophobia. For instance, cases with photophobia exhibit enhanced thalamic, trigeminal nuclei, superior colliculus, and cortical gyri activities. Such observations reinforce the idea of a light-pain matrix and help delineate the pathophysiological processes involved.

Genetic and Molecular Studies
Research in genetics and molecular biology has notably advanced the scope of diagnostics for photophobia. The discovery of particular genes and the molecular mechanisms regulating light sensitivity and pain appreciation offer greater prospects for precision diagnostics. As an example, photophobia has been associated with mutations in the CGRP receptor in animal models; thus, possible genetic markers for this condition have been established. Such data can assist in creating screening procedures that determine the possible risk for photophobia.

Therapeutics Development for Photophobia

The therapeutics of photophobia employs approaches that deal with the mechanisms of light sensitivity and pain perception. One potential avenue is the development of CGRP receptor antagonists which have been shown to be effective in treating migraines and related photophobia. These medications block the CGRP receptor to decrease pain signaling pathway activation. Also, some neuroprotective agents that act on the melanopsin pathway are being investigated for the therapeutics of photophobia associated with retinal conditions.

Our Services

Protheragen offers unparalleled preclinical therapeutics development services targeted at solving photophobia. Due to our extensive preclinical research experience, we are an ideal partner for clients seeking to develop novel therapeutics for this debilitating condition since we offer a complete range of diagnostics and preclinical therapeutics development services.

Diagnostics Development

Therapeutic Development

Disease Models

Nitroglycerin (NTG) Induction Rodent Models
Casein Kinase 1δ (CK1δ) Gene Mutation Rodent Models
Dura Mater Electrical Stimulation Rabbit Models

At Protheragen, we recognize that every client has unique needs and goals. Therefore, we offer a range of customized services to meet the specific requirements of our clients. If you are interested in our services, please feel free to contact us.

References

Zou, Xiaodong, et al. "Photophobia and Visual Triggers in Vestibular Migraine." Neurology and Therapy 13.4 (2024): 1191-1201.
Katz, Bradley J., and Kathleen B. Digre. "Diagnosis, pathophysiology, and treatment of photophobia." Survey of ophthalmology 61.4 (2016): 466-477.